Filing Details

Accession Number:
0001209191-19-041299
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-03 20:01:12
Reporting Period:
2019-07-01
Accepted Time:
2019-07-03 20:01:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897448 Amarin Corp Plc AMRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408920 T Joseph Kennedy C/O Amarin Pharma, Inc.
1430 Route 206
Bedminster NJ 07921
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-07-01 2,604 $1.40 60,806 No 4 M Direct
Ordinary Shares Acquisiton 2019-07-01 18,764 $2.50 79,570 No 4 M Direct
Ordinary Shares Acquisiton 2019-07-01 3,438 $2.95 83,008 No 4 M Direct
Ordinary Shares Acquisiton 2019-07-01 2,438 $3.80 85,446 No 4 M Direct
Ordinary Shares Disposition 2019-07-01 54,186 $19.52 31,260 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-07-01 2,604 $0.00 2,604 $1.40
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-07-01 18,764 $0.00 18,764 $2.50
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-07-01 3,438 $0.00 3,438 $2.95
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-07-01 2,438 $0.00 2,438 $3.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,228 2026-01-31 No 4 M Direct
0 2025-07-06 No 4 M Direct
65,310 2027-02-01 No 4 M Direct
75,560 2028-02-01 No 4 M Direct
Footnotes
  1. The option exercises and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  3. Please see the section titled "Remarks" below for additional information.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.18 to $19.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 29, 2016.
  6. On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on July 31, 2015.
  7. On February 1, 2017, the Reporting Person was granted an option to purchase 165,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 28, 2017.
  8. On February 1, 2018, the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 28, 2018.